Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dalroi who wrote (1631)	6/9/2003 7:17:04 AM
From: Icebrg	Read Replies (1) of 3044

Stefaan Velcade has been approved. I believe they should have a fair idea about how much revenue this product will generate. this is the problem imo , its not known, agree they can project sales in mm but in the rest of the cancers ??? They have to be conservative here. There will of course be some off-label use of Velcade well before 2006 and maybe even some on-label new uses, but they shouldn't count on that just yet. If things exceed expectations they can always press the accelerator again. There will always be opportunities available in biotech. But to start heavy braking in say 2005, because revenue is not reaching the levels they had hoped for this year or because they are running out of funds might be too difficult. The roll-out of Velcade will also require a lot of resources. And the more successful the development is the more it will cost. Regardless what they have guessed, they have guessed something and they are now adjusting their cost side. Remember, they will also be losing o lot of their collaborative research support over the next couple of years. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next